For the quarter ending 2025-09-30, BIXT has $156,294 in assets. $3,060,937 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 14,499 | 3,144 | ||
| Total current assets | 14,499 | 3,144 | ||
| Intangibles, net | 141,795 | 144,357 | ||
| Total assets | 156,294 | 147,501 | ||
| Accounts payable and accrued expenses-Related Party | 823,453 | 688,722 | ||
| Accounts payable and accrued expenses-Nonrelated Party | 322,457 | 22,948 | ||
| Un-issued shares liability-Nonrelated Party | 38,522 | 15,602 | ||
| Un-issued shares liability-Related Party | 60,894 | 26,242 | ||
| Loan from affiliates-Related Party | 541,405 | 502,255 | ||
| Other short-term loans | 50,000 | 38,000 | ||
| Convertible notes payable, net of premium and discount | 805,000 | 805,000 | ||
| Derivative liability | 419,206 | 684,002 | ||
| Total current liabilities | 3,060,937 | 2,782,771 | ||
| Total liabilities | 3,060,937 | 2,782,771 | ||
| Preferred stock, 0.001 par value 50,000,000 shares authorized, and 43,429,639 and 43,158,248 issued and outstanding as at september 30, 2025, and as at december 31, 2024, respectively | 43,429 | 43,429 | ||
| Common stock, 0.001 par value 400,000,000 shares authorized 88,992,243 and 86,782,908 issued and outstanding as at september 30, 2025, and december 31, 2024, respectively | 88,992 | 88,992 | ||
| Stock subscription | 13,353 | - | ||
| Additional paid-in capital | 17,471,675 | 17,471,675 | ||
| Accumulated deficit | -20,522,092 | -20,239,366 | ||
| Total stockholders deficit | -2,904,643 | -2,635,270 | ||
| Total liabilities and stockholders equity | 156,294 | 147,501 | ||
BIOXYTRAN, INC (BIXT)
BIOXYTRAN, INC (BIXT)